The protocol's emphasis on personalization testing to reveal which of the 36 potential contributing factors are active in an individual is a strength because it prevents indiscriminate supplement stacking and focuses effort where lab evidence points to need, and the supplement component is designed to address inflammation, energy metabolism, neurotransmitter support, detoxification, and the gut-brain connection in parallel
Among these, PTX, a methylxanthine derivative with vasodilatory properties, has emerged as a particularly promising therapeutic agent
Moreover the dose modification factor (DMF) for the PtII agents were lower than those for PtIV agents in the three cell lines
Managing side effects: practical protocols Having covered individual side effects, let us consolidate the management strategies into practical protocols you can implement
The observed plasma increase in adenosine could be due to a decrease in adenosine deaminase activity, inhibition of adenosine kinase, or an increase in 5-nucleotidase, all of which can occur in the presence of oxidative stress [7072]